Further insights into the antinociceptive potential of a peptide disrupting the N-type calcium channel–CRMP-2 signaling complex
Open Access
- 1 September 2011
- journal article
- research article
- Published by Taylor & Francis in Channels
- Vol. 5 (5) , 449-456
Abstract
The N-type voltage-gated calcium channel ( Cav2.2) has gained immense prominence in the treatment of chronic pain. While decreased channel function is ultimately anti-nociceptive, directly targeti...Keywords
This publication has 33 references indexed in Scilit:
- Blocking painful interactionsNature Reviews Neuroscience, 2011
- Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca2+ channel complexNature Medicine, 2011
- Merging Structural Motifs of Functionalized Amino Acids and α-Aminoamides Results in Novel Anticonvulsant Compounds with Significant Effects on Slow and Fast Inactivation of Voltage-Gated Sodium Channels and in the Treatment of Neuropathic PainACS Chemical Neuroscience, 2011
- TRPA1 receptors mediate environmental irritant-induced meningeal vasodilatationPain, 2011
- Regulation of N-type voltage-gated calcium channels (Cav2.2) and transmitter release by collapsin response mediator protein-2 (CRMP-2) in sensory neuronsJournal of Cell Science, 2009
- An Atypical Role for Collapsin Response Mediator Protein 2 (CRMP-2) in Neurotransmitter Release via Interaction with Presynaptic Voltage-gated Calcium ChannelsJournal of Biological Chemistry, 2009
- NMDA Di-Heteromeric Receptor Populations and Associated Proteins in Rat HippocampusJournal of Neuroscience, 2007
- CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathyBrain, Behavior, and Immunity, 2007
- Delayed Functional Expression of Neuronal Chemokine Receptors Following Focal Nerve Demyelination in the Rat: A Mechanism for the Development of Chronic Sensitization of Peripheral NociceptorsMolecular Pain, 2007
- Powerful antinociceptive effects of the cone snail venom-derived subtype-selective NMDA receptor antagonists conantokins G and TPain, 2003